BIT 0.00% 3.2¢ biotron limited

Structural insight into the role of novel SARS-CoV-2 E protein:...

  1. 229 Posts.
    lightbulb Created with Sketch. 355

    Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies

    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0237300

    While there are no antiviral drugs or effective vaccines against COVID-19 on the market; we leverage the existing knowledge of viroporins and structural modeling to explain a putative mechanism involving E protein in SARS-CoV-2 related infection. The development of therapeutic approaches is being hindered due to the lack of understanding of molecular mechanisms and players responsible for this novel viral infection [

    Frankly, I think Biotron were ahead of their time investing all recourses on the E Protein, time will tell (hopefully not too long) but i i think investors will be rewarded in the near future!
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.3¢ 3.3¢ 3.2¢ $17.40K 542.8K

Buyers (Bids)

No. Vol. Price($)
1 17000 3.1¢
 

Sellers (Offers)

Price($) Vol. No.
3.3¢ 120000 2
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.